LORATADINE TABLETS

The Defense Logistics Agency awarded Delivery Order SPE2DP26F7470 to DMS PHARMACEUTICAL GROUP INC, a small disadvantaged and women-owned small business with CAGE code 1UNB0, for the supply of 7.000 packages of LORATADINE TABLETS (NSN 6505013770448) at a unit price of $20.01, resulting in a total contract value of $140.07. The order was issued under the basic indefinite-delivery, indefinite-quantity contract SPE2DX25D9900 and is subject to FOB Destination terms, requiring delivery to Fort Bragg, North Carolina, no later than July 29, 2026. All shipments must be traceable via non-parcel post methods with clear labeling in Block 1 as SPE2DX-25-D-9900 and Block 2 as SPE2DP-26-F-7470, along with the Transportation Control Number W91KBP60890105; while no specific MIL-STD or preservation requirements are listed, compliance with federal pharmaceutical identification standards is implied through the use of NSN and NDC codes. Inspection and acceptance occur at the destination by the government, with payment handled by DEF FIN AND ACCOUNTING SVC, BSM using accounting code BX: 97X4930 5CBX 001 2620 S33189 and payment code SL4701. The contracting officer, Lisa Quinn, and administrative contact Shairy M. Cartagena oversee contract administration, with no modifications, options, or special requirements beyond those outlined in the basic contract referenced in Section B. The offeror’s small business and socioeconomic certifications were verified at time of award and trigger reporting obligations under FAR 52.219-8, -9, and -25, though no subcontracting plan is referenced. Bar-coding and packaging materials are not explicitly mandated, but compliance with standard DoD tracking systems is expected. No clauses, certifications outside those noted, or evaluation factors were included in the provided documentation, suggesting this is a streamlined, low-value procurement executed under existing framework contract authority with minimal administrative overhead.